1
Yiwen Tang, Stephen D Pacetti, Qing Lin, Ni Ding: Purification of polymers for coating applications. Squire Sanders & Dempsey, July 26, 2011: US07985441 (12 worldwide citation)

Various embodiments of methods and devices for coating stents are described herein. Among these embodiments are methods of manufacturing an implantable medical device by purifying a polymer with a fluid capable of swelling the polymer, and subsequently coating a device with the purified polymer or f ...


2
Syed Faiyaz Ahmed Hossainy, Yiwen Tang, Homayon Askaryar, Qing Lin, Thierry Glauser: Methods of forming coatings with a crystalline or partially crystalline drug for implantable medical devices. Abbott Cardiovascular Systems, Squire Sanders, June 17, 2014: US08753709 (12 worldwide citation)

Methods for making coatings on an implantable device, such as a drug-eluting stent. The coatings comprise a polymer and a drug in a crystalline or partially crystalline form. In addition, implantable devices produced by the methods and methods of using the coated implantable devices are described.


3
Alan Qing Lin Zhu: Modular fence. Thomas I Rozsa, March 25, 2008: US07347412 (12 worldwide citation)

A modular picket fence including a pair of vertical posts positioned at suitable distance and adapted to be secured to a suitable support surface. A pair of horizontal upper and lower rails extend between and secured to the vertical posts. The upper rail has a plurality of apertures which are aligne ...


4
Syed Faiyaz Ahmed Hossainy, Yiwen Tang, Homayon Askaryar, Qing Lin, Thierry Glauser: Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS. Advanced Cardiovascular Systems, Squires Sanders, October 8, 2013: US08551512 (10 worldwide citation)

Methods for making coatings on an implantable device such as a drug-eluting stent comprising a polymer and nano or microparticles of a drug in slow-dissolving polymorph, implantable devices produced by the methods and methods of using the coatings are provided.


5
Thierry Nivaggioli, Jane Guo Shiah, Qing Lin: Extended release biodegradable ocular implants. Allergan, Jennifer C Cheng, Joel B German, Debra D Condino, April 1, 2014: US08685435 (7 worldwide citation)

Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 50 days and one year, or longer.


6
Christopher J Soares, Michael R Hanley, Diana Y Lewis, David Geoffrey Parkes, Carolyn M Jodka, Kathryn S Prickett, Soumitra S Ghosh, Christine Marie Mack, Qing Lin: Amylin family peptides. Amylin Pharmaceuticals, February 14, 2012: US08114958 (5 worldwide citation)

The present invention relates to obesity related polypeptides (ORPs), related nucleic acids, expression constructs, host cells, and processes production of the obesity related polypeptides. The ORPs of the invention include one or more amino acid sequence modifications. In addition, methods and comp ...


7
Hui Chen Zhao, Qing Lin Zhou: Printed circuit board. Hong Fu Jin Precision, Hon Hai Precision, Altis Law Group, December 13, 2011: US08076590 (3 worldwide citation)

A printed circuit board includes a first signal via, a second signal via, and a first ground via. A distance between the first ground via and the first signal via is substantially equal to a distance between the first ground via and the second signal via.


8
Christopher J Soares, Michael R Hanley, Diana Y Lewis, David G Parkes, Carolyn M Jodka, Kathryn S Prickett, Soumitra S Ghosh, Christine M Mack, Qing Lin: Methods for treatment using amylin family peptides. Amylin Pharmaceuticals, AstraZeneca Pharmaceuticals, Womble Carlyle Sandridge & Rice, Mark Pino, Alireza Behrooz, December 3, 2013: US08598120 (2 worldwide citation)

The present invention relates to novel compounds having a function of a peptide in the amylin family, related nucleic acids, expression constructs, host cells, and processes production of the compounds. The compounds of the invention include one or more amino acid sequence modifications. In addition ...


9
Soumitra S Ghosh, Josue Alfaro Lopez, Lawrence J D Souza, Odile Esther Levy, Qing Lin, Christopher J Soares: Peptide-peptidase inhibitor conjugates and methods of using same. Amylin Pharmaceuticals, Astrazeneca Pharmaceuticals, Womble Carlyle Sandridge & Rice, Mark J Pino, Alireza Behrooz, June 24, 2014: US08759295 (2 worldwide citation)

Peptide-peptidase inhibitor conjugate molecules are disclosed. These conjugate molecules are useful as agents for the treatment and prevention of metabolic and cardiovascular diseases, disorders, and conditions. Such diseases, conditions and disorders include, but are not limited to, hypertension, d ...


10
Qing Lin, Bin Gan, Xiaoyun Jing: Systems and methods for wireless communications. Huawei Technologies, Conley Rose P C, Grant Rodolph, April 27, 2010: US07706276 (2 worldwide citation)

A method to improve TCP throughput by separating TCP acknowledgment flow from TCP normal data flow in a wireless communications environment. This method creates dedicated signaling air interface link and signaling A10 link for TCP acknowledgment flow and assigns a higher priority value to TOS field ...